declines breast cancer whi apparent impact hormone therapy pubmed ncbi abstract large numbers women stopped taking hormone therapies ht estrogen/progestin ep formulations women's health initiative trial detected elevated risks breast cancer ep users halted july num recent reports substantial significant declines population-based breast cancer incidence hormone-sensitive forms num num events linked commentary considers evidence linking mass cessation ht num breast cancer incidence declines num quantifies potential impact cessation burden breast cancer 
